Rockville biotechnology company Cellphire is the latest receipient of funding via the State’s InvestMaryland program, receiving $1 million last month!
Cellphire is developing stabilized cellular products, including freeze-dried platelets that can be stored for years and used in a range of advanced therapeutic and diagnostic applications including sports medicine, plastic surgery and dentistry. The company received a contract last year worth up to $57 million from the Biomedical Advanced Research Defense Authority, a division of U.S. Department of Health & Human Services. The InvestMaryland funding will be used to continue development of the company’s freeze-dried platelet product, Thrombosomes, and move it closer to winning FDA approval.
{iframe}http://www.choosemontgomerymd.com/features/rockville-based-cellphire-gets-1-million-from-investmaryland-program#.U7WYqo1dW3g{/iframe}